OXB
"OXB" is a word mark owned by Oxford BioMedica plc, filed at the USPTO on June 24, 2024. It is registered and covers classes 40 and 42.
- Status
- Registered
- Since December 9, 2025
- Filed
- June 24, 2024
- Registered
- December 9, 2025
- Priority date
- June 17, 2024
- Claimed from United Kingdom
- Application no.
- 98615252
- Registration no.
- 8055616
- Office
- USPTO
- United States Patent and Trademark Office
- Mark type
- Word mark
- 2 classes
Who owns OXB
The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.
Owner
Oxford BioMedica plc
Oxford, United Kingdom
Representative
Rebeccah Gan
Muncy, Geissler, Olds & Lowe, P.C.
What the mark covers
The products and services OXB is filed for, grouped by Nice class.
Custom and contract manufacture of products relating to biotechnology, namely, gene therapy, and viral, retroviral, lentiviral and non-viral preparations and biopharmaceutical products, viral and non-viral vectors, and vaccines
Biotechnology research and laboratory analytic and diagnostic services in the field of nanotechnology, gene therapy, vector-based delivery systems and viral vector manufacturing; design of biotechnology manufacturing facilities; quality control and validation services in the field of nanotechnology, gene therapy, vector-based delivery systems and viral vector manufacturing; product development consultancy in the field of nanotechnology, gene therapy and vector-based delivery systems; product, viral vector and analytic assay development for others; laboratory services for biomanufacturing; research and development services for bio-manufacturing; genetic engineering laboratories and biochemistry laboratories; scientific and technological services and research in the field of nanotechnology, gene therapy, vector-based delivery systems and viral vector manufacturing; industrial analysis services in the field of biotechnology; provision of information relating to scientific research; providing scientific information in the field of nanotechnology, gene therapy, vector-based delivery systems and viral vector manufacturing; research and scientific analysis relating to drug discovery and development for others; scientific research and technology advisory services; scientific research and technology consultancy; scientific research and development; scientific research in the field of biotechnology and pharmaceuticals; management of scientific research projects; advisory services relating to scientific and clinical research; biological research; providing clinical and medical research information in the field of nanotechnology, gene therapy, vector-based delivery systems and viral vector manufacturing; clinical research in the field of nanotechnology, gene therapy, vector-based delivery systems and viral vector manufacturing; Scientific research in the nature of conducting clinical trials for others; bio-manufacturing development services
What has happened so far
Steps recorded by the USPTO, newest first.
- Notice of registration confirmation emailed
- Registered-principal register
- 1(b) basis deleted; proceed to registration
- Case assigned to intent to use paralegal
- Notice of allowance cancelled
- Teas delete 1(b) basis received
- Noa e-mailed - sou required from applicant
- Official gazette publication confirmation e-mailed
- Published for opposition
- Notification of notice of publication e-mailed
10 earlier steps on the official record.
About OXB
Who owns the trademark "OXB"?
The USPTO trademark "OXB" (application 98615252) is owned by Oxford BioMedica plc.
What is the status of "OXB"?
Its status at the USPTO is: registered.
When was "OXB" registered?
It was registered on December 9, 2025.
Get this data via the API
Everything on this page comes from the Signa API. Pull OXB and marks like it into your own product with one request.
GET/v1/trademarks/{id}The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/eventsEvery step in the office history
GET/v1/proceedings?trademark_id={id}Oppositions and cancellations against the mark
ID=tm_019d2937-3494-71fe-aa48-0a157b76767a
curl https://api.signa.so/v1/trademarks/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"id": "tm_019d2937-3494-71fe-aa48-0a157b76767a",
"object": "trademark",
"mark_text": "OXB",
"status": {
"primary": "active",
"stage": "registered"
},
"office_code": "US",
"application_number": "98615252",
"filing_date": "2024-06-24",
"nice_classes": [
40,
42
],
"owners": [
{
"name": "Oxford BioMedica plc",
"entity_id": "ent_019eb700-044a-7657-a0f2-c34038cbd3ce"
}
]
}